ProxiCor Extracellular Matrix Reduces Complications, Readmissions Following Pericardial ...
Medical Health News,
— Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the Journal of Cardiothoracic…
— Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the Journal of Cardiothoracic…
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day…
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day…
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30- Day…
SILVER SPRING, Md.--(Business Wire)--Aziyo® Biologics, Inc., a fully integrated regenerative medicine company, today announced…
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day…
00:00 UTC Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-D…
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day…
A prospective, multi-center, single-arm study was conducted to assess the clinical outcomes of patients undergoing pericardial…